These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1599518)

  • 1. Effect of food on the bioavailability of low-dose methotrexate in patients with rheumatoid arthritis.
    Oguey D; Kölliker F; Gerber NJ; Reichen J
    Arthritis Rheum; 1992 Jun; 35(6):611-4. PubMed ID: 1599518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraindividual variability of the bioavailability of low dose methotrexate after oral administration in rheumatoid arthritis.
    Lebbe C; Beyeler C; Gerber NJ; Reichen J
    Ann Rheum Dis; 1994 Jul; 53(7):475-7. PubMed ID: 7944622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splitting high-dose oral methotrexate improves bioavailability: a pharmacokinetic study in patients with rheumatoid arthritis.
    Hoekstra M; Haagsma C; Neef C; Proost J; Knuif A; van de Laar M
    J Rheumatol; 2006 Mar; 33(3):481-5. PubMed ID: 16463431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis.
    Hoekstra M; Haagsma C; Neef C; Proost J; Knuif A; van de Laar M
    J Rheumatol; 2004 Apr; 31(4):645-8. PubMed ID: 15088287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis.
    Bannwarth B; Péhourcq F; Schaeverbeke T; Dehais J
    Clin Pharmacokinet; 1996 Mar; 30(3):194-210. PubMed ID: 8882301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of oral vs. subcutaneous low-dose methotrexate in patients with Crohn's disease.
    Kurnik D; Loebstein R; Fishbein E; Almog S; Halkin H; Bar-Meir S; Chowers Y
    Aliment Pharmacol Ther; 2003 Jul; 18(1):57-63. PubMed ID: 12848626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate kinetics in rheumatoid arthritis: is there an interaction with nonsteroidal antiinflammatory drugs?
    Ahern M; Booth J; Loxton A; McCarthy P; Meffin P; Kevat S
    J Rheumatol; 1988 Sep; 15(9):1356-60. PubMed ID: 3199396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Compared bioavailability of methotrexate administered orally or intramuscularly in rheumatoid arthritis].
    Auvinet B; Jarrier I; Le Levier F; Pegon Y; Turcant A; Allain P
    Presse Med; 1992 May 2-9; 21(17):822. PubMed ID: 1535146
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of food on the bioavailability of oral methotrexate in children.
    Dupuis LL; Koren G; Silverman ED; Laxer RM
    J Rheumatol; 1995 Aug; 22(8):1570-3. PubMed ID: 7473485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of ingestion of ferrous sulfate on the absorption of oral methotrexate in patients with rheumatoid arthritis.
    Hamilton SF; Campbell NR; Kara M; Watson J; Connors M
    J Rheumatol; 2003 Sep; 30(9):1948-50. PubMed ID: 12966595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate in rheumatoid arthritis. An update.
    Bannwarth B; Labat L; Moride Y; Schaeverbeke T
    Drugs; 1994 Jan; 47(1):25-50. PubMed ID: 7510620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The population pharmacokinetics of long-term methotrexate in rheumatoid arthritis.
    Godfrey C; Sweeney K; Miller K; Hamilton R; Kremer J
    Br J Clin Pharmacol; 1998 Oct; 46(4):369-76. PubMed ID: 9803986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coadministration of naproxen and low-dose methotrexate in patients with rheumatoid arthritis.
    Stewart CF; Fleming RA; Arkin CR; Evans WE
    Clin Pharmacol Ther; 1990 Apr; 47(4):540-6. PubMed ID: 2328562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chloroquine reduces the bioavailability of methotrexate in patients with rheumatoid arthritis. A possible mechanism of reduced hepatotoxicity.
    Seideman P; Albertioni F; Beck O; Eksborg S; Peterson C
    Arthritis Rheum; 1994 Jun; 37(6):830-3. PubMed ID: 8003056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The issue of bioavailability of oral low dose methotrexate: should we choose only 10 mg of MTX a week in conjunction with anti-TNF therapy?
    Zeidler H
    Ann Rheum Dis; 2014 Aug; 73(8):e50. PubMed ID: 24764450
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate.
    Carmichael SJ; Beal J; Day RO; Tett SE
    J Rheumatol; 2002 Oct; 29(10):2077-83. PubMed ID: 12375315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate bioavailability after oral and subcutaneous dministration in children with juvenile idiopathic arthritis.
    Tuková J; Chládek J; Nemcová D; Chládková J; Dolezalová P
    Clin Exp Rheumatol; 2009; 27(6):1047-53. PubMed ID: 20149329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies of quality and bioavailability of methotrexate in Thai patients with rheumatoid arthritis.
    Manorot M; Rojanasathien N; Louthrenoo W; Tonsuwannont W; Teekachunhatean S
    J Med Assoc Thai; 1998 Dec; 81(12):978-85. PubMed ID: 9916387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of low dose methotrexate bioavailability: oral solution, oral tablet, subcutaneous and intramuscular dosing.
    Jundt JW; Browne BA; Fiocco GP; Steele AD; Mock D
    J Rheumatol; 1993 Nov; 20(11):1845-9. PubMed ID: 8308768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.